Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Treace Medical Concepts (TMCI) over the last 5 years, with Q3 2025 value amounting to 0.3%.

  • Treace Medical Concepts' Return on Capital Employed rose 400.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.28% for FY2024, which is 400.0% up from last year.
  • Latest data reveals that Treace Medical Concepts reported Return on Capital Employed of 0.3% as of Q3 2025, which was up 400.0% from 0.29% recorded in Q2 2025.
  • Over the past 5 years, Treace Medical Concepts' Return on Capital Employed peaked at 0.02% during Q1 2021, and registered a low of 0.34% during Q3 2024.
  • In the last 5 years, Treace Medical Concepts' Return on Capital Employed had a median value of 0.26% in 2023 and averaged 0.22%.
  • In the last 5 years, Treace Medical Concepts' Return on Capital Employed plummeted by -2200bps in 2022 and then skyrocketed by 500bps in 2023.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Return on Capital Employed stood at 0.14% in 2021, then tumbled by -100bps to 0.27% in 2022, then increased by 6bps to 0.26% in 2023, then fell by -21bps to 0.31% in 2024, then increased by 2bps to 0.3% in 2025.
  • Its Return on Capital Employed stands at 0.3% for Q3 2025, versus 0.29% for Q2 2025 and 0.29% for Q1 2025.